NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Active Not RecruitingN/A

Sponsor: M.D. Anderson Cancer Center

Conditions: COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Neuropathy

Interventions: Quality-of-Life Assessment, Questionnaire Administration

Countries: United States

This study investigates the experiences of cancer patients with neuropathy during the COVID-19 pandemic to learn how the COVID-19 pandemic affects their quality of life and clinical outcomes. This study will also explore whether there are differences between patients who received neurofeedback (NFB, a type of therapy that is thought to help normalize brain activity) and those who did not. Learning about quality of life in cancer patients with neuropathy during the COVID-19 pandemic may help guide development of programs and policies to improve chronic pain patient care and outcomes during a major global healthcare crisis.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Must have participated in one of the following protocols: 2015-0399, 2012-0642, or 2010-0675
* Has an active email address or can be contacted by MyChart or personal email

Exclusion Criteria:

* No evidence of consent from prior clinical trials

Locations (1)

Houston, Texas, United States